These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 25272558)

  • 1. Should I prevent my patient from developing depression after stroke? What is the best available option?
    Affan M; Shaikh Q; Kamal AK
    J Pak Med Assoc; 2014 May; 64(5):603. PubMed ID: 25272558
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication and talk therapy help prevent depression after a stroke. Antidepressants and problem-solving therapy can prevent or delay the onset of post-stroke depression.
    Duke Med Health News; 2008 Aug; 14(8):6-7. PubMed ID: 19123257
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for Patients. Prevention of depression in patients treated for chronic hepatitis C virus infection with interferon-alpha.
    Ann Intern Med; 2012 Jul; 157(2):I-40. PubMed ID: 22801693
    [No Abstract]   [Full Text] [Related]  

  • 4. Escitalopram for the prevention of peginterferon-α2a-associated depression.
    Schaefer M; Berg T; Sarkar S; Neumann K
    Ann Intern Med; 2013 Jan; 158(2):140. PubMed ID: 23318324
    [No Abstract]   [Full Text] [Related]  

  • 5. Escitalopram for the prevention of peginterferon-α2a-associated depression.
    Landman GW
    Ann Intern Med; 2013 Jan; 158(2):139-40. PubMed ID: 23318323
    [No Abstract]   [Full Text] [Related]  

  • 6. Does citalopram effectively treat post-stroke depression?: A protocol for systematic review and meta analysis.
    Hu J; Ma L; Yang ZY
    Medicine (Baltimore); 2020 Jun; 99(26):e20608. PubMed ID: 32590736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief report: citalopram in child and adolescent depression with anxiety.
    Schaller JL; Behar D
    MedGenMed; 2001 Oct; 3(5):1. PubMed ID: 11698908
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of herpes zoster, occurring 4 and 6 weeks after the initiation of citalopram treatment.
    Spyropoulou AC
    Psychiatry Res; 2009 Aug; 168(3):265. PubMed ID: 19560214
    [No Abstract]   [Full Text] [Related]  

  • 9. Should I prevent my patient from developing depression after stroke? What is the best available option?
    Affan M; Shaikh Q; Kamal AK
    J Pak Med Assoc; 2014 Feb; 64(2):224. PubMed ID: 24640821
    [No Abstract]   [Full Text] [Related]  

  • 10. Spontaneous orgasm started with venlafaxine and continued with citalopram.
    Yanik M
    Can J Psychiatry; 2004 Nov; 49(11):786. PubMed ID: 15633860
    [No Abstract]   [Full Text] [Related]  

  • 11. Variants in PDE11A and PDE1A are not associated with citalopram response.
    Teranishi KS; Slager SL; Garriock H; Kraft JB; Peters EJ; Reinalda MS; Jenkins GD; McGrath PJ; Hamilton SP
    Mol Psychiatry; 2007 Dec; 12(12):1061-3. PubMed ID: 18043711
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
    Wand AP
    Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Treating Mothers' Depression on Children's Well-Being.
    Coiro MJ
    Am J Psychiatry; 2015 May; 172(5):408-9. PubMed ID: 25930128
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment research of intermediate severity depression: what is useful for the routine patient?].
    MMW Fortschr Med; 2012 Feb; 154(2):69. PubMed ID: 22352257
    [No Abstract]   [Full Text] [Related]  

  • 16. [Escitalopram: a chiral agent for treatment of depression].
    Overlack M; Davids E; Gastpar M
    Med Monatsschr Pharm; 2004 May; 27(5):148-51. PubMed ID: 15171592
    [No Abstract]   [Full Text] [Related]  

  • 17. A stroke patient with a non-convulsive status epilepticus during citalopram therapy.
    Hagebeuk EE; Tans JT; de Regt EW
    Eur J Neurol; 2002 May; 9(3):319-20. PubMed ID: 11985646
    [No Abstract]   [Full Text] [Related]  

  • 18. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
    Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Efficacy of citalopram on climacteric symptoms.
    Panchovska MS; Atanasova PA; Firkova EI
    Menopause; 2007; 14(6):1069-70; author reply 1070-1. PubMed ID: 17975520
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopharmacology of smoking cessation in patients with mental illness.
    Selby P
    J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.